Aims: Young women with acute myocardial infarction (AMI) have a higher risk of adverse outcomes than men. However, it is unclear how young women with AMI are different from young men across a spectrum of characteristics. We sought to compare young women and men at the time of AMI on six domains of demographic and clinical factors in order to determine whether they have distinct profiles. Methods and results: Using data from Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO), a prospective cohort study of women and men aged ⩽55 years hospitalized for AMI (n = 3501) in the United States and Spain, we evaluated sex differences in demographics, healthcare access, cardiovascular risk and psychosocial factors, symptoms and pre-hospital delay, clinical presentation, and hospital management for AMI. The study sample included 2349 (67%) women and 1152 (33%) men with a mean age of 47 years. Young women with AMI had higher rates of cardiovascular risk factors and comorbidities than men, including diabetes, congestive heart failure, chronic obstructive pulmonary disease, renal failure, and morbid obesity. They also exhibited higher levels of depression and stress, poorer physical and mental health status, and lower quality of life at baseline. Women had more delays in presentation and presented with higher clinical risk scores on average than men; however, men presented with higher levels of cardiac biomarkers and more classic electrocardiogram findings. Women were less likely to undergo revascularization procedures during hospitalization, and women with ST segment elevation myocardial infarction were less likely to receive timely primary reperfusion. Conclusions: Young women with AMI represent a distinct, higher-risk population that is different from young men.
Translational perspective
Young women and men with acute myocardial infarction (AMI) have distinct risk factor profiles and clinical presentations. In general, young women with AMI have a higher prevalence of cardiovascular risk factors, comorbidities, and psychosocial risk factors, and they are more likely to present with longer delays to presentation, atypical symptoms, fewer diagnostic findings on electrocardiogram (ECG), and poorer clinical risk scores. Additional studies are needed in order to understand how sociodemographic and clinical risk factors contribute to the onset, development, and prognosis of AMI in young women and whether the pathophysiology of AMIs in young women is fundamentally distinct from that in young men. In addition, future research should investigate delays in diagnosis and treatment in the young in order to identify systems-level strategies for reducing delays in care.
Young and middle-aged women are at high risk of adverse outcomes after AMI. Studies indicate that women younger than 55 years of age experience two-to three-fold higher hospital mortality after AMI and a 50% higher risk of death over 2 years compared with similarly aged men. [1] [2] [3] Additionally, young women are more likely to report higher rates of angina, lower health-related quality of life, and reduced physical and mental functioning after discharge than men. [4] [5] [6] Yet little is known about whether young and middle-aged women with AMI have a profile that is different from men at the time that they present to the hospital.
We do have some information on sex differences in young AMI patients, but it is incomplete. Data from national registries and administrative claims suggest that young women with AMI may be sicker on admission and receive less effective care during hospitalization. 1, 3, [7] [8] [9] [10] [11] [12] Yet these studies have not been designed to study young women specifically and, thus, findings are based on small numbers of young women and have been limited to common cardiovascular risk factors and complications in older populations. Prospective cohort studies of young and middle-aged patients with AMI, such as GENESIS-PRAXY and Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO), have revealed some sex differences in demographics, cardiovascular risk factors, symptoms, and treatment [13] [14] [15] [16] ; however, these studies focused on a limited number of variables from specific risk factor domains. To date, no study has comprehensively assessed sex differences across a breadth of sociodemographic characteristics, comorbidities, presentations, treatments, or complications in order to determine whether young and middle-aged women with AMI have an overall profile that is different from men. In addition, prior studies have omitted many potentially important variables and risk factor domains, such as socioeconomic status, health insurance, healthcare access and utilization, non-cardiovascular comorbidities, laboratory and ECG findings, admission and discharge medications, and in-hospital complications. Because AMI occurs in the context of an individual and multiple risk factors may contribute to prognosis independently or in combination, a comprehensive comparison of young women and men with AMI across multiple domains is imperative for understanding sex differences in the pathophysiology and prognosis of AMI in young patients.
The VIRGO study is designed to characterize young and middle-aged women with AMI. 17 With detailed clinical information from patient interviews and chart abstractions, the VIRGO study offers the opportunity to comprehensively evaluate sex differences in clinical presentation and hospital course in order to determine the extent to which young women and men with AMI have similar or distinct profiles. VIRGO included a diverse range of patients with AMI recruited from more than 100 centers in the United States. The aims of this study were to compare young and middle-aged women and men hospitalized for AMI on six domains: (1) demographics and socioeconomic status; (2) healthcare access and use prior to admission; (3) cardiovascular risk factors, comorbidities, and psychosocial factors; (4) symptoms and pre-hospital delay; (5) clinical presentation on admission; and (6) hospital management and inhospital complications. We hypothesized that young women with AMI would differ from young men on several domains, making them a distinct population.
Methods

The VIRGO study
The VIRGO study is the largest prospective observational study to date of young and middle-aged women and men with AMI and was designed to examine sex differences in the presentation, treatment, and outcomes of young and middle-aged patients with AMI. Details on the study design and methodology have been reported previously. 17 In brief, young and middle-aged patients with AMI were enrolled from 103 hospitals in the United States and 24 hospitals in Spain between August 2008 and January 2012 using a 2:1 female-to-male enrollment ratio. Eligible patients were between 18 and 55 years of age, met AMI criteria, and presented or transferred to an enrolling institution within the first 24 hours of hospital presentation. AMI criteria included: (1) an increase in cardiac biomarkers (troponin I or T or creatine kinase-MB) with at least one value >99th percentile of the upper reference limit within 24 hours of admission; and (2) supporting evidence of myocardial ischemia, including symptoms of ischemia, ECG changes indicative of new ischemia (ST segment changes, left bundle branch block (LBBB), or the development of pathological Q waves), or other evidence of myocardial necrosis on imaging. 18 Patients who developed elevated cardiac markers as a complication of elective coronary revascularization were not eligible for VIRGO. Additional exclusion criteria included the inability to speak English or Spanish, the inability to provide informed consent, or the inability to be contacted for follow-up. Of the 5585 who met the eligibility criteria, 3572 patients were enrolled in VIRGO. Of these, we included 3501 patients (2349 women and 1152 men) in our analyses from the United States and Spain. The most common cause for exclusion was refusing informed consent. Enrolled and non-enrolled patients had similar demographic characteristics.
Information on baseline patient characteristics and clinical course was obtained by medical chart abstraction and standardized in-person interviews performed by trained personnel during the index admission. Institutional review board approval was obtained at each participating center, and all patients provided written informed consent to participate.
Variable definitions
Our primary variable of interest was patient sex (women versus men). Information on patient demographics, socioeconomic status, healthcare access, psychosocial risk factors, and symptoms was self-reported by the patient. Psychosocial factors were assessed using previously validated scales: the Patient Health Questionnaire-9 for depressive symptomatology, 19 the ENRICHD Social Support Inventory for social support, 20 the Perceived Stress Scale for perceived stress, 21 the Short Form-12 physical and mental component scales for general health status, 22 the Seattle Angina Questionnaire for disease-specific functional status, 23 and the Euro-Quality of Life for health-related quality of life. 24 Data on medical history, comorbidities, time to presentation, and clinical presentation were largely derived from the medical chart; however, in some cases, information from both the medical chart and patient interviews was combined in order to ensure variable completeness. Clinical severity was assessed using Killip class, which classifies patients according to signs of heart failure, and the Global Registry of Acute Coronary Events (GRACE) score, which predicts in-hospital and 6-month mortality risk. 25 An expert team of reviewers affiliated with the Yale Coordinating Center independently adjudicated the ECG findings. In-hospital course, including therapies received, admission and discharge medications, in-hospital complications, length of stay, and disposition, were obtained from chart abstraction. Details on the variable definitions are provided in Supplemental Table 1 .
Statistical analyses
We compared baseline variables between women and men using chi-square or Fisher's exact tests for categorical variables and Student's t-tests or Mann-Whitney U-tests for continuous variables. Categorical variables are presented as numbers (%) and continuous variables are presented as means (SD) or medians (interquartile ranges). All analyses were performed in SAS version 9.2 (SAS Institute, Cary, NC).
Results
This VIRGO study included 2349 women and 1152 men in the United States and Spain aged 18-55 years with AMI. The average age of both women and men in the sample was 47 (SD: 6) years. Compared with men, women were more likely to self-report as black, unemployed, and divorced, separated, or widowed (all p < 0.01) ( Table 1 ). Women generally reported lower total household incomes than men and experienced more difficulty making ends meet financially (p < 0.01).
Fewer women were uninsured, but significantly more had government insurance (Medicare, Medicaid, or Veterans Affairs) ( Table 2 ). More women than men reported having a primary care provider (90% versus 82%, p < 0.01), but the percentages of men and women seeing general practitioners versus specialists for primary care were similar. Despite higher rates of insurance and primary care, women still reported more difficulty receiving medical care before hospitalization for AMI (p = 0.01).
At the time of AMI, women were significantly more likely to have a history of diabetes, congestive heart failure (CHF), stroke, chronic obstructive pulmonary disease (COPD), chronic renal failure, and thyroid disorders than men, and they were more likely to have a higher body mass index and to report insufficient physical activity (all p < 0.01) ( Table 3 ). Rates of undiagnosed diabetes were similar between women and men. Overall, women had a higher risk factor burden than men, with significantly more women having three or more cardiovascular risk factors (diabetes, hypertension, hypercholesterolemia, smoking, and obesity) (p < 0.01). Women were also more likely to have a history of cancer, autoimmune disorders, and psychiatric disorders than men (all p < 0.01), although the prevalence of these conditions was low in the overall population. In contrast, young men with AMI were more likely to have a history of hypercholesterolemia and alcohol abuse (both p < 0.01). There were no differences in the prevalence rates of hypertension, prior coronary artery disease, or cocaine use between the sexes (all p > 0.1).
There were large differences in psychosocial risk factors between young women and men with AMI (Table 3) . Women were significantly more likely to have been diagnosed previously with depression and to meet the criteria for moderate depression on the Patient Health Questionnaire-9 scale (p < 0.01). They also reported higher levels of perceived stress and poorer physical and mental health status on average than men (all p < 0.01), but comparable levels of social support ( Figure 1 ). On disease-specific measures, women reported more anginarelated limitations and lower health-related quality of life on both the Seattle Angina Questionnaire and the Euro-Quality of Life (all p < 0.01).
The majority of women (77%) and men (83%) reported chest pain typical of AMI (Table 4 ). The second most common symptom in women was nausea (45%), followed by shortness of breath (44%). The reverse was true in men (44% had shortness of breath and 35% reported nausea). Approximately half of young women and men thought that something was wrong with their heart when they first experienced symptoms; however, more men than women reported that providers were able to correctly identify their heart problem at the point of care (87% versus 76%, p < 0.01). Women were slightly less likely than men to consider themselves at risk of heart disease or to have been told that they were at risk of heart disease prior to AMI. Additionally, women had significantly longer delays from symptom onset to presentation (>6 hours) (p < 0.01).
At the time of hospital presentation, men had higher systolic and diastolic blood pressures and higher median levels of peak cardiac marker (troponin and creatine kinase-MB) elevations than women (all p < 0.01) ( Table 5 ). There were no sex differences in the percentage of patients presenting with low blood pressure (systolic <90 mmHg or diastolic <50 mmHg). Men were more likely to have ST-segment elevation AMIs and new pathological Q waves on ECG (both p < 0.01); however, women had slightly more severe AMIs as assessed by Killip class and GRACE scores (both p < 0.05) ( Figure 2) .
Given the higher rates of ST segment elevation myocardial infarction in men, a greater proportion of men was eligible for primary reperfusion therapy ( Table 6 ). Of those who were eligible, fewer women received acute reperfusion therapy, and more women received these therapies outside of the recommended timeframes (doorto-needle time >30 minutes: 55.1% versus 40.9%; doorto-balloon time >90 minutes: 40.6% versus 29.2%). Cardiac catheterization was performed in >98% of men and women in VIRGO; however, significantly fewer women underwent percutaneous coronary intervention or coronary artery bypass grafting procedures than men (p < 0.01). Over 28% of women did not receive any revascularization procedures, compared with only 13% of men. Among patients without contraindications, there were no differences in receipt of medications on admission; however, men were more likely to be prescribed statins and angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers at discharge (both p < 0.01). Women had slightly longer median lengths of stay than men (p = 0.01). No differences in other procedures or inhospital complications, including re-infarction, cardiac arrhythmias, or renal failure, were observed between women and men (all p > 0.1).
Discussion
In our study, we found that compared with men, young and middle-aged women who are hospitalized with AMI have distinct risk factor profiles and clinical presentations. We found that women with AMI had a higher burden of cardiovascular risk factors and significantly more comorbidities than men. However, we also identified additional sex differences, extending beyond traditional clinical characteristics. First, women with AMI were more likely to have lower socioeconomic status as assessed by employment, income, and financial strain. Second, they reported higher levels of psychosocial risk factors including depression and stress, poorer physical and mental health status, and lower quality of life at the time of AMI. Third, women had more delays in symptom onset to presentation, presented with higher GRACE and Killip scores, and were less likely to receive timely reperfusion therapy. Taken together, these findings suggest that young and middle-aged women with AMI represent a fundamentally distinct, higher-risk population than men, which may contribute to their poorer prognosis over the long term.
This study is the first comprehensive evaluation of sex differences in baseline risk factors, clinical presentation, and in-hospital course of young and middle-aged women and men admitted for AMI. Similarly to previous studies, we found that women had more traditional cardiovascular risk factors, 1, 3, [7] [8] [9] [10] 13 were less likely to present with typical chest pain or diagnostic findings on ECG, 1, 3, 11 and were less likely to receive timely reperfusion. 1, 8, 13 Our findings add to previous reports by identifying sex differences in several additional clinical risk factors and comorbidities. Compared with men, women had significantly higher rates of diabetes, CHF, prior stroke, COPD, chronic renal failure, cancer, autoimmune disease, thyroid disorders, and psychiatric disorders. In addition, comorbidities and risk factors that are typically higher in older male AMI populations (e.g. prior coronary artery disease (CAD) and smoking) were comparable in men and women. These observations suggest that young and middle-aged women with AMI represent a sicker population than men of the same age.
In addition to clinical factors, we identified sex differences in several demographic and psychosocial risk factors. Women in our study were significantly more likely to be divorced, separated, or widowed than men. In addition, they were significantly more likely to be unemployed, to have lower household incomes, and to report financial stress. Studies in older AMI populations have similarly reported higher rates of unmarried status and unemployment in women. 5, 26 Perhaps due to these socioeconomic strains or other life events, women in our study also reported higher levels of perceived stress and depression than men on average. Indeed, other analyses from VIRGO show that men and women with PHQ-9 scores of ⩾9 were less likely to be married, to work full-time or part-time, and to have health insurance. 27 Nearly half of women and a quarter of men reported a previous diagnosis of depression or were taking anti-depressive medications on arrival. These rates are significantly higher than those reported in studies of older AMI populations, which have ranged from 7% to 33%. 28 Prior studies have hypothesized that depression may increase a woman's risk of cardiovascular disease by elevating atherosclerotic and inflammatory biomarkers, reducing pulse rate variability, and enhancing platelet activation. 29 Interestingly, we did not observe differences in social support between women and men in VIRGO. However, we did find that women reported poorer general and angina-related functional status and lower quality of life at baseline, which may compound the effects of psychosocial risk factors such as depression and stress.
The study design precluded us from evaluating sex differences in hospital mortality, which was <1% in VIRGO. Because VIRGO enrolled patients who survived long enough to be admitted and consented into the study, these patients likely represent a healthier cohort than all young and middle-aged patients with AMI. Although there are few nationally representative studies of the United States with which to compare our patient profile, a study of young women with AMI using administrative claims data from the Healthcare Cost and Utilization Project Nationwide Inpatient Sample (HCUP-NIS) offers some insight into the representativeness of our sample. 10 In general, the composition of patients in VIRGO was similar to that of the HCUP-NIS sample, which showed a higher proportion of black patients and higher rates of hypertension, diabetes, CHF, cerebrovascular disease, renal failure, and COPD in women than men. These findings support the representativeness of the cohort to the broader United States population of young patients with AMI.
Several studies lend support to a biological mechanism for the sex differences in clinical presentation and prognosis in young patients with AMI. Given the cardioprotective effects of estrogen, a greater risk factor burden may be needed to incur an AMI, which may explain the differences in baseline risk factors between men and women at the time of presentation for AMI. 30 Alternatively, young women who develop atherosclerosis early in life may be predisposed to more aggressive forms of CAD. 11 In fact, prior studies have found that young women likely develop CAD via different physiological pathways than older women or men. 29 Data from the Women's Ischemia Syndrome Evaluation (WISE) study group have shown that ischemic heart disease in women is characterized by more diffuse coronary disease and fewer obstructive lesions than men. 31, 32 In particular, young women with AMI have significantly less narrowing of the coronary arteries 33, 34 and are more likely to experience disease of the coronary microvasculature 35 or spontaneous coronary artery dissection. 36 These differences in the pathophysiology of CAD may explain why women in VIRGO had more atypical symptoms, lower peak biomarker (troponin and creatine kinase-MB) levels, and fewer diagnostic findings (LBBB, ST elevation, and Q waves) on ECG, and why clinicians were less likely to attribute women's AMI symptoms to the heart. Such delays in symptom recognition combined with fewer diagnostic laboratory and ECG findings may explain why women were less likely to receive fibrinolytic therapy or percutaneous coronary intervention and were more likely to experience delays in reperfusion.
Our study has several implications for future research evaluating sex disparities in AMI outcomes in young patients. First, we found that young and middle-aged women and men with AMI represent two very different populations of patients with respect to pre-hospital risk. Compared with men, young women had more demographic and psychosocial risk factors, greater comorbidity, and Women (red) had higher GRACE risk scores (p = 0.001) at the time of presentation for acute myocardial infarction and slightly longer lengths of hospital stay (p = 0.01) than men. GRACE: Global Registry of Acute Coronary Events. poorer functional status and quality of life at baseline. Additional studies are needed in order to understand how these risk factors contribute to the onset, development, and prognosis of AMI in young women and whether the pathophysiology of AMIs in young women is fundamentally distinct from that in men. Specific attention should be paid to these non-traditional risk factors given the high rates of psychosocial risk factors such as depression and financial strain. Second, young women had longer delays to presentation, more atypical symptoms, and fewer diagnostic laboratory and ECG findings, which may have contributed to delays in diagnosis and treatment. Although prior studies have identified such delays in older women as well, 37 future studies should investigate the timing and process of AMI diagnosis in young patients in order to identify systemslevel strategies for reducing delays in care. This study has some limitations. Because only patients who survived long enough to be admitted to the hospital and consented were enrolled in VIRGO, we lacked information on patients who died prior to arrival and thus are unable to draw conclusions about sex differences in sudden or early cardiac deaths. Nevertheless, we might expect sex differences in risk factors and clinical presentation to be even more pronounced in the entire cohort if young women had higher rates of in-hospital mortality as suggested by prior studies. 1, 2 Similarly, because in-hospital interviews were conducted after the AMI, patients may have recalled their experiences differently than they would have before the event. In addition, patients may have been inclined to answer more negatively on some questionnaire items, such as the stress, health status, and quality of life measures, given their recent experiences. As such, patient responses to these items may not accurately reflect their pre-hospital state. However, we do not anticipate differential recall by sex.
In summary, we identified important sex differences in demographic, psychosocial, and clinical risk factors for AMI, which suggest that young and middle-aged women and men with AMI represent distinct populations with different risk profiles. These differences in pre-hospital risk and clinical presentation may be due to differences in the etiology and pathophysiology of AMI in young women, which may also contribute to their poorer prognosis after AMI. Although men constitute the majority of patients in other studies of young patients with AMI, our findings suggest that young women with AMI represent a unique population with different experiences from those of men and so warrant particular attention. Additional research is needed
